Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets - PubMed (original) (raw)
. 1998 Jan 1;160(1):87-94.
Affiliations
- PMID: 9551959
Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets
A Raziuddin et al. J Immunol. 1998.
Abstract
Natural killer cells mediate the specific rejection of bone marrow cell (BMC) allografts in lethally irradiated mice. The Ly-49 family of molecules present on subsets of murine NK cells appears capable of binding class I MHC molecules, resulting in transmission of an inhibitory signal to the NK cell. These Ly-49 family members have been shown to have an immunoreceptor tyrosine-based inhibitory motif that is responsible for the inhibitory signal. However, a new Ly-49 family member was found that lacks this motif, Ly-49D, and evidence suggests that this may be an activating receptor. We therefore compared the role of the activating Ly-49 member with NK cells bearing inhibitory Ly-49 receptors in BMC rejection. Depletion of Ly-49D+ NK cells in H-2b mice abrogated their ability to reject H-2d BMC allografts. Similarly, Ly-49C+ NK cells also were shown to mediate the specific rejection of H-2d BMC. When both subsets were depleted, an additive enhancement of BMC engraftment was observed, indicating that both subsets play a role in the rejection of allogeneic H-2-homozygous H-2d BMC. However, rejection of H-2(b x d) or D8 (H-2b, Dd transgene) BMC allografts was unaffected by Ly-49C+ NK cell depletion in H-2b mice. In marked contrast, depletion of Ly-49D+ NK cells in H-2b mice totally abrogated the rejection of H-2(b x d) heterozygous BMC in support of in vitro data suggesting that Ly-49D+ NK cells receive activating signals. Therefore, NK subsets demonstrate a differential ability to reject H-2 homozygous and heterozygous BMC.
Similar articles
- NK cell subsets in the regulation of murine hematopoiesis. I. 5E6+ NK cells promote hematopoietic growth in H-2d strain mice.
Murphy WJ, Raziuddin A, Mason L, Kumar V, Bennett M, Longo DL. Murphy WJ, et al. J Immunol. 1995 Sep 15;155(6):2911-7. J Immunol. 1995. PMID: 7673708 - Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
Raziuddin A, Longo DL, Mason L, Ortaldo JR, Murphy WJ. Raziuddin A, et al. Int Immunol. 1996 Dec;8(12):1833-9. doi: 10.1093/intimm/8.12.1833. Int Immunol. 1996. PMID: 8982767 - Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
George TC, Ortaldo JR, Lemieux S, Kumar V, Bennett M. George TC, et al. J Immunol. 1999 Aug 15;163(4):1859-67. J Immunol. 1999. PMID: 10438920 - The immunobiology of natural killer cells and bone marrow allograft rejection.
Barao I, Murphy WJ. Barao I, et al. Biol Blood Marrow Transplant. 2003 Dec;9(12):727-41. doi: 10.1016/j.bbmt.2003.09.002. Biol Blood Marrow Transplant. 2003. PMID: 14677112 Review. - A family of murine NK cell receptors specific for target cell MHC class I molecules.
Yokoyama WM, Daniels BF, Seaman WE, Hunziker R, Margulies DH, Smith HR. Yokoyama WM, et al. Semin Immunol. 1995 Apr;7(2):89-101. doi: 10.1006/smim.1995.0013. Semin Immunol. 1995. PMID: 7579199 Review.
Cited by
- Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.
Nakamura MC, Linnemeyer PA, Niemi EC, Mason LH, Ortaldo JR, Ryan JC, Seaman WE. Nakamura MC, et al. J Exp Med. 1999 Feb 1;189(3):493-500. doi: 10.1084/jem.189.3.493. J Exp Med. 1999. PMID: 9927511 Free PMC article. - Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.
Alhajjat AM, Strong BS, Lee AE, Turner LE, Wadhwani RK, Ortaldo JR, Heusel JW, Shaaban AF. Alhajjat AM, et al. J Immunol. 2015 Aug 15;195(4):1506-16. doi: 10.4049/jimmunol.1500463. Epub 2015 Jul 1. J Immunol. 2015. PMID: 26136432 Free PMC article. - A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells.
Huntington ND, Xu Y, Nutt SL, Tarlinton DM. Huntington ND, et al. J Exp Med. 2005 May 2;201(9):1421-33. doi: 10.1084/jem.20042294. J Exp Med. 2005. PMID: 15867094 Free PMC article. - Immunotherapy of cancer for the elderly patient: does allogeneic bone marrow transplantation after nonmyeloablative conditioning provide a new option?
Zöller M. Zöller M. Cancer Immunol Immunother. 2004 Aug;53(8):659-76. doi: 10.1007/s00262-004-0503-2. Epub 2004 Apr 6. Cancer Immunol Immunother. 2004. PMID: 15067430 Free PMC article. Review. - Natural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.
Kijima M, Gardiol N, Held W. Kijima M, et al. PLoS One. 2011;6(11):e27639. doi: 10.1371/journal.pone.0027639. Epub 2011 Nov 23. PLoS One. 2011. PMID: 22132120 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials